Found 4 hits for monomerid = 144765 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Somatostatin receptor type 2
(Homo sapiens (Human)) | BDBM144765
(US8952128, 24)Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r| Show InChI InChI=1/C77H99N17O10S/c1-46(95)68-76(104)92-61(36-47-17-5-3-6-18-47)69(97)82-31-14-12-25-58(86-66(96)45-105-44-50-35-55-54-22-15-26-57-67(54)52(42-85-57)40-65(55)94(2)43-50)70(98)87-60(27-16-32-83-77(79)80)71(99)89-62(37-48-19-7-4-8-20-48)73(101)90-63(38-49-28-33-81-34-29-49)74(102)91-64(39-51-41-84-56-23-10-9-21-53(51)56)75(103)88-59(72(100)93-68)24-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,41-42,46,50,55,58-65,68,84-85,95H,11-14,16,24-25,27,30-32,35-40,43-45,78H2,1-2H3,(H,82,97)(H,86,96)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,83)/t46-,50-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/s2 | KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| 0.0800 | -13.8 | n/a | n/a | n/a | n/a | n/a | 7.6 | 25 |
Ipsen Pharma S.A.S.
US Patent
| Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w... |
US Patent US8952128 (2015)
BindingDB Entry DOI: 10.7270/Q2057DNG |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 5
(Homo sapiens (Human)) | BDBM144765
(US8952128, 24)Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r| Show InChI InChI=1/C77H99N17O10S/c1-46(95)68-76(104)92-61(36-47-17-5-3-6-18-47)69(97)82-31-14-12-25-58(86-66(96)45-105-44-50-35-55-54-22-15-26-57-67(54)52(42-85-57)40-65(55)94(2)43-50)70(98)87-60(27-16-32-83-77(79)80)71(99)89-62(37-48-19-7-4-8-20-48)73(101)90-63(38-49-28-33-81-34-29-49)74(102)91-64(39-51-41-84-56-23-10-9-21-53(51)56)75(103)88-59(72(100)93-68)24-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,41-42,46,50,55,58-65,68,84-85,95H,11-14,16,24-25,27,30-32,35-40,43-45,78H2,1-2H3,(H,82,97)(H,86,96)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,83)/t46-,50-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/s2 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 2.39 | -11.8 | n/a | n/a | n/a | n/a | n/a | 7.6 | 25 |
Ipsen Pharma S.A.S.
US Patent
| Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w... |
US Patent US8952128 (2015)
BindingDB Entry DOI: 10.7270/Q2057DNG |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 1
(Homo sapiens (Human)) | BDBM144765
(US8952128, 24)Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r| Show InChI InChI=1/C77H99N17O10S/c1-46(95)68-76(104)92-61(36-47-17-5-3-6-18-47)69(97)82-31-14-12-25-58(86-66(96)45-105-44-50-35-55-54-22-15-26-57-67(54)52(42-85-57)40-65(55)94(2)43-50)70(98)87-60(27-16-32-83-77(79)80)71(99)89-62(37-48-19-7-4-8-20-48)73(101)90-63(38-49-28-33-81-34-29-49)74(102)91-64(39-51-41-84-56-23-10-9-21-53(51)56)75(103)88-59(72(100)93-68)24-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,41-42,46,50,55,58-65,68,84-85,95H,11-14,16,24-25,27,30-32,35-40,43-45,78H2,1-2H3,(H,82,97)(H,86,96)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,83)/t46-,50-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/s2 | KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 47.7 | -9.98 | n/a | n/a | n/a | n/a | n/a | 7.6 | 25 |
Ipsen Pharma S.A.S.
US Patent
| Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w... |
US Patent US8952128 (2015)
BindingDB Entry DOI: 10.7270/Q2057DNG |
More data for this
Ligand-Target Pair | |
D(2) dopamine receptor
(Homo sapiens (Human)) | BDBM144765
(US8952128, 24)Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r| Show InChI InChI=1/C77H99N17O10S/c1-46(95)68-76(104)92-61(36-47-17-5-3-6-18-47)69(97)82-31-14-12-25-58(86-66(96)45-105-44-50-35-55-54-22-15-26-57-67(54)52(42-85-57)40-65(55)94(2)43-50)70(98)87-60(27-16-32-83-77(79)80)71(99)89-62(37-48-19-7-4-8-20-48)73(101)90-63(38-49-28-33-81-34-29-49)74(102)91-64(39-51-41-84-56-23-10-9-21-53(51)56)75(103)88-59(72(100)93-68)24-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,41-42,46,50,55,58-65,68,84-85,95H,11-14,16,24-25,27,30-32,35-40,43-45,78H2,1-2H3,(H,82,97)(H,86,96)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,83)/t46-,50-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/s2 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 175 | n/a | n/a | n/a | n/a | n/a | n/a | 7.6 | n/a |
Ipsen Pharma S.A.S.
US Patent
| Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra... |
US Patent US8952128 (2015)
BindingDB Entry DOI: 10.7270/Q2057DNG |
More data for this
Ligand-Target Pair | |
Search and Browse
